nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

15.03.2019 | Short Communication

Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation

verfasst von: Sanjeev Kumar Sharma, Divya Doval, Vipin Khandelwal, Meet Kumar, Dharma Choudhary

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Risk of diabetes mellitus increases after solid organ and hematopoietic stem cell transplantation. Diabetic ketoacidosis has been reported after solid organ transplantation in patients receiving tacrolimus but has rarely been reported after stem cell transplantation. The major risk factors for diabetic ketoacidosis are immunosuppressive drugs used after transplantation. We report here three cases of allogenic stem cell transplant who developed diabetic ketoacidosis while on treatment with tacrolimus. The drug was stopped in all the cases and patients were treated with insulin therapy resulting in complete recovery from diabetic ketoacidosis.

Fortune K, Couriel D (2009) Tacrolimus in hematopoietic stem cell transplantation. Expert Opin Drug Metab Toxicol 5(7):835–841CrossRef

Koehler MT, Howrie D, Mirro J, Neudorf S et al (1995) FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. Bone Marrow Transplant 15(6):895–899PubMed

Kramer BK, Montagnino G, Castillo D et al (2005) Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transpl 20:968–973CrossRef

Salvadori M, Bertoni E, Rosati A, Zanazzi M (2003) Post-transplant diabetes mellitus. J Nephrol 16(5):626–634PubMed

Greenspan LC, Gitelman SE, Leung MA et al (2002) Increased incidence in post-transplant diabetes mellitus in children: a case control analysis. Pediatr Nephrol 17:1–5CrossRef

Traggiai C, Stanhope R, Nussey S, Leiper AD (2002) Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 40:128–129CrossRef

Griffith ML, Jagasia M, Jagasia SM (2010) Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract 16(4):699–706CrossRef

Solmaz S, Gökgöz Z, Gereklioğlu C et al (2017) Tacrolimus-induced diabetic ketoacidosis after allogeneic bone marrow transplant. Exp Clin Transpl 15(6):702–703

Ricordi C, Zeng Y, Alezandro R et al (1991) In vivo effect of FK506 on human pancreatic islets. Transplantation 52:519–522CrossRef

10.

Duijnhoven EM, Boots JM, Christiaans MH et al (2001) Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. JASN 12:583–588PubMed

11.

Jindal RM, Sidner RA, Milgrom ML (1997) Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 16(4):242–257CrossRef

12.

Yoshida EM, Buczkowski AK, Sirrs SM, Elliott TG et al (2000) Post-transplant diabetic ketoacidosis—a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. Transpl Int 13:69–72CrossRef

13.

Montori VM, Basu A, Erwin PJ et al (2002) Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25(3):583–592CrossRef

14.

Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245CrossRef

Titel: Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation
verfasst von: Sanjeev Kumar Sharma
Divya Doval
Vipin Khandelwal
Meet Kumar
Dharma Choudhary
Publikationsdatum: 15.03.2019
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-019-01113-w

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Tacrolimus Induced Diabetic Ketoacidosis Following Hematopoietic Stem Cell Transplantation

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

The IJHBT Editorial Board’s Journey (2013–2019)

Inhibition of γ/β Globin Gene Switching in CD 34+ Derived Erythroid Cells by BCL11A RNA Silencing

Impact Analysis of the National Guidelines for Blood Donor Selection in India: A Single Center Study

Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years

Performance Evaluation of Automated Immunohematology Analyzer IH-500 for Blood Bank Testing

Left Ventricular Regional Function in Children with Beta Thalassemia with No Cardiac Manifestations (Four-Dimensional Echocardiographic Study)

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie